ArticleExperimental hematology & oncology2025

NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors.

Xia Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.